Skip to search formSkip to main contentSkip to account menu

N 0861

Known as: 9H-Purin-6-amine, N-bicyclo(2.2.1)hept-2-yl-9-methyl-, endo-(+-)-, N-0861, N0861 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Abstract— We investigated whether activation of A1 or A3 adenosine receptors (ARs) induces late preconditioning (PC) against… 
Highly Cited
1998
Highly Cited
1998
Receptor antagonists can be classified as neutral antagonists or antagonists with inverse agonist activity based on their… 
1996
1996
BACKGROUND To determine the adenosine receptor subtype selectivity of the novel antagonist N-0861, the A1 and A2 receptor… 
1996
1996
Previous studies in our laboratory identified N6-endonorbornyl-9-methyladenine (N-0861) as a highly selective (100-fold) A1… 
1995
1995
UNLABELLED N6-endonorboman-2-yl-9-methyladenine (N-0861) is a drug which inhibits the A1 adenosine receptor subtype. One proposed… 
1993
1993
OBJECTIVE The aim was to study the mechanism of global hypoxia induced atrioventricular (AV) nodal conduction block in vivo using… 
Highly Cited
1992
Highly Cited
1992
This study examines the cellular basis and specificity of the effects of adenosine on early afterdepolarizations (EADs), delayed… 
1992
1992
Activation of cardiac A1 adenosine receptors slows atrioventricular conduction and attenuates the effects of catecholamines…